77 research outputs found

    The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services

    Get PDF
    Introduction Tobacco smoking is a significant public health concern. It is estimated that more than 40,000 deaths and $6.5 billion in direct health care costs are attributable to tobacco smoking in Canada each year. Individuals who smoke tobacco or who are exposed to second-hand smoke are at increased risk of respiratory disease, cardiovascular disease and cancer. It is well known that quitting smoking can improve immediate and long-term health, yet nicotine dependence is a significant barrier to smoking cessation. Multimodal approaches that include medication and counselling services promote successful smoking cessation

    CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma.

    Get PDF
    BACKGROUND: Up to 7% of all adrenal incidentalomas (AIs) are pheochromocytomas (PCCs). In the evaluation of AI, it is generally recommended that PCC be excluded by measurement of plasma-free or 24-hour urinary fractionated metanephrines. However, recent studies suggest that biochemical exclusion of PCC not be performed for lesions with CT characteristics of an adrenocortical adenoma (ACA). AIM: To determine the proportion of PCCs with ACA-like attenuation or contrast washout on CT. METHODS: For this multicenter retrospective study, two central investigators independently analyzed the CT reports of 533 patients with 548 histologically confirmed PCCs. Data on tumor size, unenhanced Hounsfield units (HU), absolute percentage washout (APW), and relative percentage washout (RPW) were collected in addition to clinical parameters. RESULTS: Among the 376 PCCs for which unenhanced attenuation data were available, 374 had an attenuation of >10 HU (99.5%). In the two exceptions (0.5%), unenhanced attenuation was exactly 10 HU, which lies just within the range of ≤10 HU that would suggest a diagnosis of ACA. Of 76 PCCs with unenhanced HU > 10 and available washout data, 22 (28.9%) had a high APW and/or RPW, suggestive of ACA. CONCLUSION: Based on the lack of PCCs with an unenhanced attenuation of <10 HU and the low proportion (0.5%) of PCCs with an attenuation of 10 HU, it seems reasonable to abstain from biochemical testing for PCC in AIs with an unenhanced attenuation of ≤10 HU. The assessment of contrast washout, however, is unreliable for ruling out PCC

    DNA mismatch repair gene MSH6 implicated in determining age at natural menopause

    Get PDF
    notes: PMCID: PMC3976329This is a freely-available open access publication. Please cite the published version which is available via the DOI link in this record.The length of female reproductive lifespan is associated with multiple adverse outcomes, including breast cancer, cardiovascular disease and infertility. The biological processes that govern the timing of the beginning and end of reproductive life are not well understood. Genetic variants are known to contribute to ∼50% of the variation in both age at menarche and menopause, but to date the known genes explain <15% of the genetic component. We have used genome-wide association in a bivariate meta-analysis of both traits to identify genes involved in determining reproductive lifespan. We observed significant genetic correlation between the two traits using genome-wide complex trait analysis. However, we found no robust statistical evidence for individual variants with an effect on both traits. A novel association with age at menopause was detected for a variant rs1800932 in the mismatch repair gene MSH6 (P = 1.9 × 10(-9)), which was also associated with altered expression levels of MSH6 mRNA in multiple tissues. This study contributes to the growing evidence that DNA repair processes play a key role in ovarian ageing and could be an important therapeutic target for infertility.UK Medical Research CouncilWellcome Trus

    Infantile Alexander disease with late onset infantile spasms and hypsarrhythmia

    No full text
    Alexander disease (AxD) is a rare autosomal dominant leukodystrophy with three clinical subtypes: infantile, juvenile and adult. Forms differ by age of symptoms occurrence and the clinical presentation. Although recent data suggest considering only two subtypes: type I (infantile onset with lesions extending to the cerebral hemispheres); type II (adult onset with primary involvement of subtentorial structures). Dominant mutations in the glial fibrillary acidic protein (GFAP) gene in AxD cause dysfunction of astrocytes (a type III intermediate filament). The authors discuss the clinical picture of a boy with infantile form of AxD confirmed by the presence of de novo heterozygous mutation c.236G>A in the GFAP gene and without striking symptoms such as macrocephaly and with exceptional late-onset epileptic spasms with hypsarrhyth- mia on electroencephalogram (EEG)

    Synthesis and physicochemical characterization of silicafillers modified with octakis({3-methacryloxypropyl}dimethylsiloxy) octasilsesquioxane

    No full text
    Hybrid nanofillers of silica grafted with octakis({3-methacryloxypropyl}dimethylsiloxy) octasilsesquioxane were obtained by the method based on solvent evaporation with the use of both hydrated or emulsion spherical silica. Octakis({3-methacryloxypropyl}dimethylsiloxy) octasilsesquioxane was applied as a modifying agent and it was synthesized by employing the hydrosilylation reaction. The effectiveness of modification of the hybrid nanofillers obtained was verified using Fourier transform infrared spectroscopy and nuclear magnetic resonance (29Si and 13C CP MAS NMR). The products obtained were characterized by determination of their physicochemical properties and porous structure, including specific surface area, pore diameter and pore volume. Dispersion degree and particle size of the nanofillers was characterized by NIBS (Non-Invasive Back-scatter) method and laser diffraction technique, while their morphology by transmission electron microscopy

    Anhydrous calcium phosphate crystals stabilize DNA for dry storage

    No full text
    The resilience of ancient DNA (aDNA) in bone gives rise to the preservation of synthetic DNA with bioinorganic materials such as calcium phosphate (CaP). Accelerated aging experiments at elevated temperature and humidity displayed a positive effect of co-precipitated, crystalline dicalcium phosphate on the stability of synthetic DNA in contrast to amorphous CaP. Quantitative PXRD in combination with SEM and EDX measurements revealed distinct CaP phase transformations of calcium phosphate dihydrate (brushite) to anhydrous dicalcium phosphate (monetite) influencing DNA stability.ISSN:1359-7345ISSN:1364-548
    corecore